• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆固醇质量外排能力与外周动脉疾病风险:动脉粥样硬化多民族研究。

Cholesterol mass efflux capacity and risk of peripheral artery disease: The Multi-Ethnic Study of Atherosclerosis.

机构信息

Division of Cardiology, University of Southern California, Los Angeles, CA, USA.

Department of Biostatistics, University of Washington, Seattle, WA, USA.

出版信息

Atherosclerosis. 2020 Mar;297:81-86. doi: 10.1016/j.atherosclerosis.2020.02.007. Epub 2020 Feb 15.

DOI:10.1016/j.atherosclerosis.2020.02.007
PMID:32097805
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7253335/
Abstract

BACKGROUND AND AIMS

We aimed to assess the relationship of HDL (high-density lipoprotein)-mediated cholesterol mass efflux capacity (CMEC) with risk of incident peripheral artery disease (PAD).

METHODS

CMEC was measured in 1458 Multi-Ethnic Study of Atherosclerosis participants between 2000 and 2002 as part of a case-control study matched for incident cardiovascular disease and progression of carotid plaque by ultrasound. Incident clinical PAD, adjudicated on the basis of a positive history for the presence of disease-related symptoms or treatment, was ascertained through 2015 in 1419 individuals without clinical PAD at baseline. Subclinical PAD, defined as an ankle-brachial index (ABI) ≤1.0, was assessed among 1255 individuals with a baseline ABI >1.0 and at least one follow-up ABI measurement 3-10 years later. Cox proportional hazards and relative risk regression modeling per SD increment of CMEC were used to determine the association of CMEC with clinical and subclinical PAD, respectively.

RESULTS

There were 38 clinical PAD and 213 subclinical PAD events that occurred over a mean follow-up of 6.0 and 6.5 years respectively. After adjustment for age, gender, and race, higher CMEC levels were not associated with clinical PAD (hazard ratio 1.25; 95% CI 0.89, 1.75) or subclinical PAD (risk ratio 1.02; 95% CI, 0.94, 1.11).

CONCLUSIONS

These findings suggest that HDL-mediated cholesterol efflux is not significantly associated with incident clinical and subclinical PAD.

摘要

背景和目的

我们旨在评估高密度脂蛋白(HDL)介导的胆固醇质量外排能力(CMEC)与外周动脉疾病(PAD)发病风险的关系。

方法

在 2000 年至 2002 年间,作为一项病例对照研究的一部分,对 1458 名动脉粥样硬化多民族研究参与者进行了 CMEC 测量,该研究通过超声匹配心血管疾病发病和颈动脉斑块进展。在基线时无临床 PAD 的 1419 名个体中,通过 2015 年的确定,根据存在与疾病相关的症状或治疗的阳性病史,确定了临床 PAD 的发病情况。在基线 ABI>1.0 且至少有一次后续 ABI 测量在 3-10 年内的 1255 名个体中,评估了亚临床 PAD,定义为踝臂指数(ABI)≤1.0。使用 Cox 比例风险和相对风险回归模型,每 SD 递增 CMEC 来确定 CMEC 与临床和亚临床 PAD 的相关性。

结果

在平均随访 6.0 和 6.5 年时,分别发生了 38 例临床 PAD 和 213 例亚临床 PAD 事件。在调整年龄、性别和种族后,CMEC 水平较高与临床 PAD(风险比 1.25;95%CI 0.89,1.75)或亚临床 PAD(风险比 1.02;95%CI,0.94,1.11)无关。

结论

这些发现表明,HDL 介导的胆固醇外排与新发临床和亚临床 PAD 无明显相关性。

相似文献

1
Cholesterol mass efflux capacity and risk of peripheral artery disease: The Multi-Ethnic Study of Atherosclerosis.胆固醇质量外排能力与外周动脉疾病风险:动脉粥样硬化多民族研究。
Atherosclerosis. 2020 Mar;297:81-86. doi: 10.1016/j.atherosclerosis.2020.02.007. Epub 2020 Feb 15.
2
Association of Circulating Hepatocyte Growth Factor and Risk of Incident Peripheral Artery Disease: The Multi-Ethnic Study of Atherosclerosis.循环肝细胞生长因子与外周动脉疾病发病风险的相关性:动脉粥样硬化的多民族研究。
Angiology. 2020 Jul;71(6):544-551. doi: 10.1177/0003319720912935. Epub 2020 Mar 23.
3
Lipoprotein-Associated Phospholipase A2 and Incident Peripheral Arterial Disease in Older Adults: The Cardiovascular Health Study.脂蛋白相关磷脂酶A2与老年人外周动脉疾病的发生:心血管健康研究
Arterioscler Thromb Vasc Biol. 2016 Apr;36(4):750-6. doi: 10.1161/ATVBAHA.115.306647. Epub 2016 Feb 4.
4
GlycA, a Novel Inflammatory Marker and Its Association With Peripheral Arterial Disease and Carotid Plaque: The Multi-Ethnic Study of Atherosclerosis.糖基化终产物(GlycA),一种新型炎症标志物及其与外周动脉疾病和颈动脉斑块的关系:动脉粥样硬化的多种族研究。
Angiology. 2019 Sep;70(8):737-746. doi: 10.1177/0003319719845185. Epub 2019 Apr 28.
5
Lipoprotein-associated phospholipase A and risk of incident peripheral arterial disease in a multi-ethnic cohort: The Multi-Ethnic Study of Atherosclerosis.脂蛋白相关磷脂酶A与多族裔队列中周围动脉疾病发病风险的关系:动脉粥样硬化多族裔研究
Vasc Med. 2017 Feb;22(1):5-12. doi: 10.1177/1358863X16671424. Epub 2016 Oct 17.
6
Relationship of apolipoprotein C-III proteoform composition with ankle-brachial index and peripheral artery disease in the Multi-Ethnic Study of Atherosclerosis (MESA).载脂蛋白 C-III 蛋白亚型组成与踝臂指数和外周动脉疾病的关系:动脉粥样硬化多民族研究(MESA)。
Atherosclerosis. 2024 Aug;395:117584. doi: 10.1016/j.atherosclerosis.2024.117584. Epub 2024 May 16.
7
Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: the SURDIAGENE study.2 型糖尿病患者脂蛋白血浆浓度与下肢外周动脉疾病风险的关系:SURDIAGENE 研究。
Diabetologia. 2021 Mar;64(3):668-680. doi: 10.1007/s00125-020-05326-x. Epub 2021 Jan 6.
8
Associations of edge-detected and manual-traced common carotid artery intima-media thickness with incident peripheral artery disease: The Multi-Ethnic Study of Atherosclerosis.边缘检测和手动描记的颈总动脉内膜中层厚度与外周动脉疾病发病的相关性:动脉粥样硬化的多民族研究。
Vasc Med. 2019 Aug;24(4):306-312. doi: 10.1177/1358863X19835925. Epub 2019 Apr 26.
9
Sex and ethnic differences in the associations between lipoprotein(a) and peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis.动脉粥样硬化多族裔研究中脂蛋白(a)与外周动脉疾病关联的性别和种族差异。
J Vasc Surg. 2016 Feb;63(2):453-8. doi: 10.1016/j.jvs.2015.08.114. Epub 2015 Oct 27.
10
Cholesterol Mass Efflux Capacity, Incident Cardiovascular Disease, and Progression of Carotid Plaque.胆固醇质量外排能力、心血管事件的发生与颈动脉斑块的进展。
Arterioscler Thromb Vasc Biol. 2019 Jan;39(1):89-96. doi: 10.1161/ATVBAHA.118.311366.

引用本文的文献

1
A study on the production of extracellular vesicles derived from novel immortalized human placental mesenchymal stromal cells.一项关于源自新型永生化人胎盘间充质基质细胞的细胞外囊泡产生的研究。
Sci Rep. 2025 Jan 28;15(1):3568. doi: 10.1038/s41598-025-87371-3.
2
Racial and ethnic influences on carotid atherosclerosis: Epidemiology and risk factors.种族和民族对颈动脉粥样硬化的影响:流行病学与风险因素。
SAGE Open Med. 2024 Jun 23;12:20503121241261840. doi: 10.1177/20503121241261840. eCollection 2024.
3
Qihuang Zhuyu Formula Attenuates Atherosclerosis via Targeting PPAR to Regulate Cholesterol Efflux and Endothelial Cell Inflammation.芪黄逐瘀方通过靶向 PPAR 调节胆固醇外排和内皮细胞炎症来减轻动脉粥样硬化。
Oxid Med Cell Longev. 2022 Dec 5;2022:2226168. doi: 10.1155/2022/2226168. eCollection 2022.
4
Addressing dyslipidemic risk beyond LDL-cholesterol.解决 LDL 胆固醇以外的血脂异常风险。
J Clin Invest. 2022 Jan 4;132(1). doi: 10.1172/JCI148559.
5
Artesunate attenuates foam cell formation by enhancing cholesterol efflux.青蒿琥酯通过增强胆固醇外流来减轻泡沫细胞形成。
Ann Transl Med. 2021 Sep;9(17):1379. doi: 10.21037/atm-21-3551.
6
Cholesterol Efflux Capacity Associates with the Ankle-Brachial Index but Not All-Cause Mortality in Patients with Peripheral Artery Disease.胆固醇流出能力与外周动脉疾病患者的踝臂指数相关,但与全因死亡率无关。
Diagnostics (Basel). 2021 Aug 4;11(8):1407. doi: 10.3390/diagnostics11081407.
7
Cholesterol efflux pathways, inflammation, and atherosclerosis.胆固醇外排途径、炎症与动脉粥样硬化。
Crit Rev Biochem Mol Biol. 2021 Aug;56(4):426-439. doi: 10.1080/10409238.2021.1925217. Epub 2021 Jun 28.
8
High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives.高密度脂蛋白胆固醇外排能力与心血管疾病中的动脉粥样硬化:病理生理方面和药物治疗观点。
Cells. 2021 Mar 5;10(3):574. doi: 10.3390/cells10030574.
9
Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study.在伴有和不伴有 2 型糖尿病的冠心病患者中,胆固醇流出能力与外周动脉疾病之间的关系:来自 CORDIOPREV 研究。
Cardiovasc Diabetol. 2021 Mar 25;20(1):72. doi: 10.1186/s12933-021-01260-3.

本文引用的文献

1
HDL and Reverse Cholesterol Transport.高密度脂蛋白和胆固醇逆向转运。
Circ Res. 2019 May 10;124(10):1505-1518. doi: 10.1161/CIRCRESAHA.119.312617.
2
Cholesterol Mass Efflux Capacity, Incident Cardiovascular Disease, and Progression of Carotid Plaque.胆固醇质量外排能力、心血管事件的发生与颈动脉斑块的进展。
Arterioscler Thromb Vasc Biol. 2019 Jan;39(1):89-96. doi: 10.1161/ATVBAHA.118.311366.
3
Cholesterol efflux capacity does not associate with coronary calcium, plaque vulnerability, and telomere length in healthy octogenarians.在健康的 80 岁老人中,胆固醇外排能力与冠状动脉钙、斑块易损性和端粒长度无关。
J Lipid Res. 2018 Apr;59(4):714-721. doi: 10.1194/jlr.P079525. Epub 2018 Feb 7.
4
HDL efflux capacity, HDL particle size, and high-risk carotid atherosclerosis in a cohort of asymptomatic older adults: the Chicago Healthy Aging Study.无症状老年人群队列中高密度脂蛋白流出能力、高密度脂蛋白颗粒大小与高危颈动脉粥样硬化:芝加哥健康老龄化研究
J Lipid Res. 2017 Mar;58(3):600-606. doi: 10.1194/jlr.P069039. Epub 2017 Jan 3.
5
Intracoronary Imaging, Cholesterol Efflux, and Transcriptomes After Intensive Statin Treatment: The YELLOW II Study.经强化他汀类药物治疗后的冠状动脉内影像学、胆固醇流出和转录组学:YELLOW II 研究。
J Am Coll Cardiol. 2017 Feb 14;69(6):628-640. doi: 10.1016/j.jacc.2016.10.029. Epub 2016 Oct 29.
6
Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib.在接受依维莫司治疗的血脂异常患者中,胆固醇流出能力和前β-1 高密度脂蛋白浓度增加。
J Am Coll Cardiol. 2015 Nov 17;66(20):2201-2210. doi: 10.1016/j.jacc.2015.09.013.
7
Cholesterol efflux capacity in humans with psoriasis is inversely related to non-calcified burden of coronary atherosclerosis.银屑病患者的胆固醇流出能力与冠状动脉粥样硬化的非钙化负荷呈负相关。
Eur Heart J. 2015 Oct 14;36(39):2662-5. doi: 10.1093/eurheartj/ehv339. Epub 2015 Jul 18.
8
Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study.高密度脂蛋白胆固醇外排能力与冠心病事件发生的相关性:一项前瞻性病例对照研究。
Lancet Diabetes Endocrinol. 2015 Jul;3(7):507-13. doi: 10.1016/S2213-8587(15)00126-6. Epub 2015 May 27.
9
HDL cholesterol efflux capacity and cardiovascular events.高密度脂蛋白胆固醇流出能力与心血管事件
N Engl J Med. 2015 May 7;372(19):1870-1. doi: 10.1056/NEJMc1503139.
10
HDL cholesterol efflux capacity and incident cardiovascular events.高密度脂蛋白胆固醇流出能力与心血管事件的发生
N Engl J Med. 2014 Dec 18;371(25):2383-93. doi: 10.1056/NEJMoa1409065. Epub 2014 Nov 18.